Ontario cancer community comes together at OICR Translational Research Conference

Ask a cancer researcher: Is there a blood test for cancer?

New PFAC Chair takes lead of growing, evolving community of OICR patient partners

Ask a Cancer Researcher: How does blood change as we age?

Ask a Cancer Researcher: How can we predict if breast cancer will come back?

Ask a Cancer Researcher: What happens to samples donated to tumour banks?

Paying it forward with a patient perspective

Ask a Cancer Researcher: What is immunotherapy?

Patient partner driven to make cancer care more inclusive

Ask a Cancer Researcher: What happens after a new discovery?

Ask a Cancer Researcher: Why do we sequence tumour DNA?

‘Upswing’ in patient partnership presents opportunities for impact, says new PFAC chair

Patient perspectives fuelling translational OICR studies

Prostate cancer trial aims to deliver shorter, more effective radiotherapy thanks to advanced imaging

OICR announces funding for three new window-of-opportunity clinical trials

OICR launches new Patient Partnership Plan

New research asks if clinical trials are losing sight of what matters most to cancer patients

New Chair of patient advisory council taking OICR patient partnership into next phase

Made-in-Canada CAR-T cells save lives in promising clinical trial

Mapping the Canadian clinical trials landscape in precision oncology to identify trial opportunities for patients, clinicians and researchers

Ontario Institute for Cancer Research announces funding for sixteen studies that support early detection of cancer, the development of new diagnostics to guide therapy and improved treatment options for patients

New funding from the Ontario Institute for Cancer Research supports projects developing methods for cancer detection and tools to facilitate better treatment decisions for high-risk cancer patients

Study puts spotlight on FDA’s accelerated approval of cancer drugs

Patient reflections from the 2021 OICR Translational Research Conference